BioSpace News Archive

NeuClone Pharmaceuticals Ltd announced successful completion of monitoring visits and blood sampling for subjects in the Phase I clinical trial for its Stelara® biosimilar candidate, NeuLara.

Aimmune Therapeutics to Present at the 19 th Annual Needham Virtual Healthcare Conference

Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today provides its first quarter business update and pipeline developments. Business Update While the COVID-19 outbreak is reaching unprecedented pandemic levels globally, Seelos empathizes with those experiencing the devastating loss of life and the transformation

GenomOncology, LLC announced today that the Hawaii Pathologists’ Laboratory (HPL) has selected the GenomOncology Pathology Workbench to provide analysis services for the assay for their new Precision Medicine program.

RedHawk Holdings Corp. announced that it has named Sheriff Beauregard “Bud” Torres III, a 40-year veteran of law enforcement, to lead the Company’s First Responder marketing efforts.

The tenth annual Pharmaceutical Innovation Index, released by IDEA Pharma today, sees Roche top the industry for the first time.

Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc

SOPHiA GENETICS, leader in Data-Driven Medicine, announced today that Lara Hashimoto has joined its Executive Team as Chief Business Officer, effective April 1st.

Today Wise Therapeutics (Wise), a newly formed digital therapeutics company, launched its flagship product, Personal Zen, to assist in combating stress and anxiety. Wise is dedicated to making highly accessible, evidence-based interventions for a broad range of behavioral health problems.

Automation Anywhere, a global leader in Robotic Process Automation (RPA), today announced intelligent automation solutions to empower governments, healthcare organizations and enterprises to implement remote working and business continuity programs as they navigate the challenges caused by COVID-19.